dimethyl sulfoxide has been researched along with Transfusion Reaction in 3 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
Excerpt | Relevance | Reference |
---|---|---|
"Hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantations (HSCTs) have been largely attributed to toxicity of dimethyl sulfoxide (DMSO) for cryopreservation, but HSC products also contain various cells and plasma components." | 2.94 | Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study. ( Ashida, T; Fujii, N; Fujiwara, SI; Hirose, A; Ikeda, K; Iseki, T; Kameda, K; Kanamori, H; Kanda, J; Kasama, K; Minakawa, K; Mori, T; Muroi, K; Nagai, K; Nagamura-Inoue, T; Ohto, H; Okuyama, Y; Takahashi, T; Tanosaki, R; Yamada-Fujiwara, M, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ikeda, K | 1 |
Ohto, H | 1 |
Yamada-Fujiwara, M | 1 |
Okuyama, Y | 1 |
Fujiwara, SI | 1 |
Muroi, K | 1 |
Mori, T | 1 |
Kasama, K | 1 |
Kanamori, H | 1 |
Iseki, T | 1 |
Nagamura-Inoue, T | 1 |
Kameda, K | 1 |
Kanda, J | 1 |
Nagai, K | 1 |
Fujii, N | 1 |
Ashida, T | 1 |
Hirose, A | 1 |
Takahashi, T | 1 |
Minakawa, K | 1 |
Tanosaki, R | 1 |
Morris, C | 1 |
de Wreede, L | 1 |
Scholten, M | 1 |
Brand, R | 1 |
van Biezen, A | 1 |
Sureda, A | 1 |
Dickmeiss, E | 1 |
Trneny, M | 1 |
Apperley, J | 1 |
Chiusolo, P | 1 |
van Imhoff, GW | 1 |
Lenhoff, S | 1 |
Martinelli, G | 1 |
Hentrich, M | 1 |
Pabst, T | 1 |
Onida, F | 1 |
Quinn, M | 1 |
Kroger, N | 1 |
de Witte, T | 1 |
Ruutu, T | 1 |
Perry, S | 1 |
1 trial available for dimethyl sulfoxide and Transfusion Reaction
Article | Year |
---|---|
Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Topics: Adolescent; Adult; Age Factors; Aged; Body Weight; Bone Marrow Transplantation; Child; Child, Presch | 2020 |
2 other studies available for dimethyl sulfoxide and Transfusion Reaction
Article | Year |
---|---|
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Topics: Adolescent; Adult; Aged; Blood Preservation; Bone Marrow Cells; Cryopreservation; Cryoprotective Age | 2014 |
Problems associated with the preparation and clinical use of platelets for replacement therapy.
Topics: Antibodies; Blood Group Antigens; Blood Platelets; Blood Preservation; Blood Transfusion; Cell Survi | 1971 |